ATE513853T1 - Peptide und peptidderivate sowie pharmazeutische zusammensetzungen, die diese enthalten - Google Patents
Peptide und peptidderivate sowie pharmazeutische zusammensetzungen, die diese enthaltenInfo
- Publication number
- ATE513853T1 ATE513853T1 AT07701338T AT07701338T ATE513853T1 AT E513853 T1 ATE513853 T1 AT E513853T1 AT 07701338 T AT07701338 T AT 07701338T AT 07701338 T AT07701338 T AT 07701338T AT E513853 T1 ATE513853 T1 AT E513853T1
- Authority
- AT
- Austria
- Prior art keywords
- peg
- denotes
- residue
- alkyl
- peptides
- Prior art date
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 4
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 229920001223 polyethylene glycol Polymers 0.000 abstract 5
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 4
- 229910052739 hydrogen Inorganic materials 0.000 abstract 4
- 239000001257 hydrogen Substances 0.000 abstract 4
- 239000002202 Polyethylene glycol Substances 0.000 abstract 3
- 150000001413 amino acids Chemical class 0.000 abstract 3
- 125000000008 (C1-C10) alkyl group Chemical group 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 125000006850 spacer group Chemical group 0.000 abstract 2
- 125000005842 heteroatom Chemical group 0.000 abstract 1
- 125000004433 nitrogen atom Chemical group N* 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/745—Blood coagulation or fibrinolysis factors
- C07K14/75—Fibrinogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/36—Blood coagulation or fibrinolysis factors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Toxicology (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Dermatology (AREA)
- Virology (AREA)
- Pain & Pain Management (AREA)
- Heart & Thoracic Surgery (AREA)
- Oncology (AREA)
- Rheumatology (AREA)
- Communicable Diseases (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AT3012006 | 2006-02-23 | ||
| PCT/AT2007/000095 WO2007095660A1 (en) | 2006-02-23 | 2007-02-23 | Peptides and peptide derivatives as well as pharmaceutical compositions containing the same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE513853T1 true ATE513853T1 (de) | 2011-07-15 |
Family
ID=38042580
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT07701338T ATE513853T1 (de) | 2006-02-23 | 2007-02-23 | Peptide und peptidderivate sowie pharmazeutische zusammensetzungen, die diese enthalten |
Country Status (15)
| Country | Link |
|---|---|
| US (3) | US20110098442A1 (de) |
| EP (2) | EP1987062B1 (de) |
| JP (1) | JP2009527502A (de) |
| KR (1) | KR20090005300A (de) |
| CN (1) | CN101389653A (de) |
| AT (1) | ATE513853T1 (de) |
| AU (1) | AU2007219031B2 (de) |
| CA (1) | CA2641908A1 (de) |
| ES (1) | ES2371038T3 (de) |
| IL (1) | IL193435A0 (de) |
| MX (1) | MX2008010930A (de) |
| NO (1) | NO20084002L (de) |
| RU (1) | RU2008137796A (de) |
| WO (1) | WO2007095660A1 (de) |
| ZA (1) | ZA200807028B (de) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2331958T3 (es) * | 2004-06-25 | 2010-01-21 | FIBREX MEDICAL RESEARCH & DEVELOPMENT GMBH | Uso de peptidos derivados de la cadena b beta de fibrinogeno humano para el tratamiento del choque. |
| US8722623B2 (en) * | 2007-09-17 | 2014-05-13 | University Of Maryland, Baltimore | Compositions and methods utilizing fibrin beta chain fragments |
| WO2009096502A1 (ja) * | 2008-01-31 | 2009-08-06 | Japan As Represented By President Of National Center Of Neurology And Psychiatry | うつ病およびうつ状態のマーカーおよびそれを用いた検出・診断 |
| US20090286740A1 (en) * | 2008-05-15 | 2009-11-19 | Fibrex Medical Research & Development Gmbh | Peptides and derivatives thereof, the manufacturing thereof as well as their use for preparing a therapeutically and/or preventively active pharmaceutical composition |
| US7884074B2 (en) | 2008-05-15 | 2011-02-08 | Ikaria Development Subsidiary Two, LLC | Compounds and methods for prevention and/or treatment of inflammation using the same |
| US20090286725A1 (en) * | 2008-05-15 | 2009-11-19 | Fibrex Medical Research & Development Gmbh | Peptides and derivatives thereof, the manufacturing thereof as well as their use for preparing a therapeutically and/or preventively active pharmaceutical composition |
| US8088890B2 (en) * | 2008-09-26 | 2012-01-03 | Fibrex Medical Research & Development Gmbh | Peptides and peptidomimetic compounds, the manufacturing thereof as well as their use for preparing a therapeutically and/or preventively active pharmaceutical composition |
| WO2010043444A2 (en) * | 2008-10-15 | 2010-04-22 | Fibrex Medical Research & Development Gmbh | Pharmaceutical preparation for the treatment and/or prevention of ischemia/reperfusion injury and the sequels thereof |
| US20100152832A1 (en) * | 2008-12-12 | 2010-06-17 | Medtronic Vascular, Inc. | Apparatus and Methods for Treatment of Aneurysms With Fibrin Derived Peptide B-Beta |
| US8841257B2 (en) * | 2009-04-10 | 2014-09-23 | Board Of Regents, The University Of Texas System | Inhibitors of STAT3 and uses thereof |
| WO2017210539A1 (en) | 2016-06-02 | 2017-12-07 | University Of Maryland, Baltimore | Compositions for inhibiting fibrin-vldl receptor-dependent inflammation and methods of treatment |
| WO2019011879A1 (en) | 2017-07-09 | 2019-01-17 | Rainer Henning | THERAPEUTIC AGENT FOR THE TREATMENT OF CAPILLARY LEAK SYNDROME |
| JP7429032B2 (ja) * | 2019-12-24 | 2024-02-07 | 学校法人順天堂 | 間質性肺炎モデル非ヒト動物の作製方法 |
| EP3912679A1 (de) | 2020-05-19 | 2021-11-24 | Johann Wolfgang Goethe-Universität Frankfurt am Main | Bbeta-15-42 zur behandlung von viraler endothelitis |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4966848A (en) * | 1988-02-08 | 1990-10-30 | The General Hospital Corporation | Isolation, purification, characterization, cloning and sequencing of N α-acetyltransferase |
| US5223421A (en) * | 1989-10-25 | 1993-06-29 | The General Hospital Corporation | Identification of methionine Nα-acetyltransferase |
| US5965107A (en) * | 1992-03-13 | 1999-10-12 | Diatide, Inc. | Technetium-99m labeled peptides for imaging |
| DE69233069T2 (de) | 1991-03-15 | 2003-11-27 | Amgen Inc., Thousand Oaks | Pegylation von polypeptiden |
| US5688489A (en) * | 1995-09-15 | 1997-11-18 | Resolution Pharmaceuticals, Inc. | Non-receptor mediated imaging agents |
| US6323311B1 (en) * | 1999-09-22 | 2001-11-27 | University Of Utah Research Foundation | Synthesis of insulin derivatives |
| KR100864069B1 (ko) | 2000-12-12 | 2008-10-16 | 피브렉스 메디칼 리서치 앤드 디벨롭먼트 게엠베하 | 펩타이드 및/또는 단백질, 및 치료제 및 예방제의 제조를위한 그들의 용도 |
| DE10314329A1 (de) * | 2003-03-28 | 2004-10-21 | Zf Friedrichshafen Ag | Antriebsstrang zum Antrieb eines Mobil-Fahrzeugs |
| CA2525464A1 (en) | 2003-05-12 | 2004-11-25 | Qun Yin | Novel poly(ethylene glycol) modified compounds and uses thereof |
| ES2331958T3 (es) * | 2004-06-25 | 2010-01-21 | FIBREX MEDICAL RESEARCH & DEVELOPMENT GMBH | Uso de peptidos derivados de la cadena b beta de fibrinogeno humano para el tratamiento del choque. |
| AT502987A1 (de) * | 2005-12-23 | 2007-07-15 | Fibrex Medical Res & Dev Gmbh | Pharmazeutische zusammensetzung zur behandlung von hämorrhagischem schock und seinen folgeerscheinungen |
-
2007
- 2007-02-23 RU RU2008137796/04A patent/RU2008137796A/ru not_active Application Discontinuation
- 2007-02-23 US US12/280,543 patent/US20110098442A1/en not_active Abandoned
- 2007-02-23 WO PCT/AT2007/000095 patent/WO2007095660A1/en not_active Ceased
- 2007-02-23 US US11/678,535 patent/US7799758B2/en not_active Expired - Fee Related
- 2007-02-23 EP EP07701338A patent/EP1987062B1/de not_active Not-in-force
- 2007-02-23 ES ES07701338T patent/ES2371038T3/es active Active
- 2007-02-23 CA CA002641908A patent/CA2641908A1/en not_active Abandoned
- 2007-02-23 CN CNA2007800063032A patent/CN101389653A/zh active Pending
- 2007-02-23 AT AT07701338T patent/ATE513853T1/de active
- 2007-02-23 ZA ZA200807028A patent/ZA200807028B/xx unknown
- 2007-02-23 MX MX2008010930A patent/MX2008010930A/es unknown
- 2007-02-23 KR KR1020087023213A patent/KR20090005300A/ko not_active Withdrawn
- 2007-02-23 EP EP10009684A patent/EP2256131A1/de not_active Withdrawn
- 2007-02-23 AU AU2007219031A patent/AU2007219031B2/en not_active Ceased
- 2007-02-23 JP JP2008555560A patent/JP2009527502A/ja active Pending
-
2008
- 2008-08-13 IL IL193435A patent/IL193435A0/en unknown
- 2008-09-19 NO NO20084002A patent/NO20084002L/no not_active Application Discontinuation
-
2010
- 2010-06-22 US US12/820,804 patent/US20100279924A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US20080039388A1 (en) | 2008-02-14 |
| MX2008010930A (es) | 2008-10-29 |
| AU2007219031B2 (en) | 2011-11-03 |
| ZA200807028B (en) | 2009-11-25 |
| IL193435A0 (en) | 2011-08-01 |
| NO20084002L (no) | 2008-11-18 |
| US20100279924A1 (en) | 2010-11-04 |
| US20110098442A1 (en) | 2011-04-28 |
| AU2007219031A1 (en) | 2007-08-30 |
| RU2008137796A (ru) | 2010-03-27 |
| ES2371038T3 (es) | 2011-12-26 |
| EP2256131A1 (de) | 2010-12-01 |
| US7799758B2 (en) | 2010-09-21 |
| CA2641908A1 (en) | 2007-08-30 |
| KR20090005300A (ko) | 2009-01-13 |
| WO2007095660A1 (en) | 2007-08-30 |
| EP1987062B1 (de) | 2011-06-22 |
| CN101389653A (zh) | 2009-03-18 |
| JP2009527502A (ja) | 2009-07-30 |
| EP1987062A1 (de) | 2008-11-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE513853T1 (de) | Peptide und peptidderivate sowie pharmazeutische zusammensetzungen, die diese enthalten | |
| BRPI0413276B8 (pt) | derivado de insulina, complexo de zinco do mesmo, e, composição farmacêutica | |
| MY148258A (en) | Phenylamino-benzoxazole substituted carboxylic acids, method for their production and use thereof as medicaments | |
| ATE365213T1 (de) | Aminosäuresequenzen die die fähigkeit besitzen, die durchdringung durch eine biologische barriere erleichtern | |
| NO20085064L (no) | 4,5-difenyl-pyrimidinyl-oksy eller -merkaptosubstituerte karboksylsyrer, fremgangsmate for deres fremstilling og anvendelse derav som medikamenter | |
| DE602007009995D1 (de) | Muteine von tearlipocalin und verfahren zu deren gewinnung | |
| DE60305113T2 (de) | Borsäuresalze und deren Verwendung in der Bereitstellung von Medikamente für die Thrombosebehandlung | |
| CY1109722T1 (el) | Ενδιαμεσες ενωσεις για την παρασκευη της trans-5-chloro-2-methyl-2,3,3a,12b-tetrahydro-1h-dibenz[2,3:6,73oxepino[4,5-c]pyrrole | |
| ATE551422T1 (de) | Aprotininpolypeptide zum transport einer verbindung durch die blut-hirn-schranke | |
| PE20090711A1 (es) | Region constante de anticuerpo mutante | |
| MX2009004467A (es) | Compuestos benzoilo amino heterociclilo como activadores de la glucoquinasa (glk). | |
| NO20084577L (no) | Probiotisk stamme og antimikrobielle peptider fra disse | |
| DE602007014210D1 (de) | Prophylaktisches/therapeutisches mittel für neurodegenerative erkrankungen | |
| EA201170889A1 (ru) | Изделия на основе полимолочной кислоты и их использование | |
| JP2009527503A5 (de) | ||
| ATE458746T1 (de) | Melphalan-derivate und ihre verwendung als chemotherapeutika gegen krebs | |
| MX2010012042A (es) | Peptidos, peptidomimeticos y derivados de los mismos, su fabricacion asi como su uso para preparar una composicion farmaceutica terapeutica y/o preventivamente activa. | |
| ATE464890T1 (de) | Eine pharmazeutische zusammensetzung zur behandlung von pathologien, die durch die allgemeine immunantwort verursacht werden | |
| MX349364B (es) | Variante de alfa-1 antitripsina novedosa, método de preparación de la misma, y uso de la misma. | |
| EA200701810A1 (ru) | Производное изоксазолина и новый способ его получения | |
| CY1110401T1 (el) | Παραγωγα των 1-φαινυλαλκανοκαρβοξυλικων οξεων για την αντιμετωπιση των νευροεκφυλιστικων νοσων | |
| DE602004026514D1 (de) | Orale Zusammensetzung aus Naturstoffen zum Erhalt der richtigen Hautfeuchtigkeit | |
| NO20082127L (no) | Antagonister mot interaksjon av PF4 og Rantes | |
| RU2009117253A (ru) | Средство для лечения и/или улучшения состояния при диссеминированном внутрисосудистом свертывании | |
| DK1474439T3 (da) | Dipeptider og tripeptider med anti-inflammatorisk virkning |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1987062 Country of ref document: EP |